Subtyping based on immune cell fractions reveal heterogeneity of cardiac fibrosis in end-stage heart failure
BackgroundA central issue hindering the development of effective anti-fibrosis drugs for heart failure is the unclear interrelationship between fibrosis and the immune cells. This study aims at providing precise subtyping of heart failure based on immune cell fractions, elaborating their differences...
Main Authors: | Shangjie Zou, Bee Luan Khoo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1053793/full |
Similar Items
-
Label-free enrichment of human blast cells from whole blood for leukemia monitoring
by: Yatian Fu, et al.
Published: (2022-09-01) -
A deformability-based biochip for precise label-free stratification of metastatic subtypes using deep learning
by: Haojun Hua, et al.
Published: (2023-09-01) -
Resistin and risks of incident heart failure subtypes and cardiac fibrosis: the Multi‐Ethnic Study of Atherosclerosis
by: Xinjiang Cai, et al.
Published: (2022-10-01) -
Early detection of metastasis in ascites and peritoneal lavage – new perspectives using label-free microfluidic approaches
by: Bee Luan Khoo
Published: (2023-05-01) -
The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
by: Kazuaki Maruyama, et al.
Published: (2022-02-01)